Neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease
Authors:
- 1 December 2002
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 54 (12) , 1627-1656
Abstract
No abstract availableKeywords
This publication has 318 references indexed in Scilit:
- Role for peroxisome proliferator-activated receptor-? in Alzheimer's diseaseAnnals of Neurology, 2001
- Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosisAnnals of Neurology, 2000
- COX-2 and the cyclopentenone prostaglandins - a new chapter in the book of inflammation?Prostaglandins & Other Lipid Mediators, 2000
- Activation of NADPH Oxidase in Alzheimer's Disease BrainsBiochemical and Biophysical Research Communications, 2000
- From genotype to phenotype: A clinical, pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutationAnnals of Neurology, 1999
- Increased Expression of Cyclooxygenases and Peroxisome Proliferator-Activated Receptor-γ in Alzheimer's Disease BrainsBiochemical and Biophysical Research Communications, 1999
- No Genetic Effect of α1-Antichymotrypsin in Alzheimer DiseaseGenomics, 1996
- Role of microglia in senile plaque formationNeurobiology of Aging, 1995
- Amyloid β protein (Aβ) removal by neuroglial cells in cultureNeurobiology of Aging, 1995
- Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease corticesFEBS Letters, 1991